Tissue TransplantationComplicityFetal Tissue TransplantationPersonhoodDirected Tissue DonationLifeBeginning of Human LifeBrain Tissue TransplantationAborted FetusTissue and Organ ProcurementHospitals, StateOrgan TransplantationLiver TransplantationHand TransplantationTransplantation, HeterotopicTransplantation, HomologousTransplantationTissue DonorsTransplantation ImmunologyKidney TransplantationGraft SurvivalBone Marrow TransplantationDrug TolerancePregnant WomenPrimary Ovarian InsufficiencySkin TransplantationEthics, MedicalHematopoietic Stem Cell TransplantationCryopreservationHeart TransplantationImmune ToleranceTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningTransplantation ToleranceGraft RejectionOvaryIslets of Langerhans TransplantationPancreas TransplantationTransplantation ChimeraCell TransplantationGlucose Tolerance TestImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicTreatment OutcomeLiving DonorsCord Blood Stem Cell TransplantationHeart-Lung TransplantationTime FactorsImmunosuppressionPeripheral Blood Stem Cell TransplantationRetrospective StudiesHistocompatibility TestingLiver FailurePostoperative ComplicationsTransplantation, HeterologousWaiting ListsRecurrenceHistocompatibilityMesenchymal Stem Cell TransplantationCorneal TransplantationTacrolimusHematologic NeoplasmsWhole-Body IrradiationCyclosporineFollow-Up StudiesMice, Inbred C57BLSurvival AnalysisCadaverSurvival RateSelf ToleranceLiver DiseasesFacial TransplantationDonor SelectionOrgan PreservationT-LymphocytesBusulfanTransplantsHLA AntigensRisk FactorsRats, Inbred LewKidney Failure, ChronicLeukemiaCombined Modality TherapyAntilymphocyte SerumGlucose IntoleranceLiverBronchiolitis ObliteransMice, Inbred BALB CChimerismBlood GlucoseAcute DiseasePostoperative PeriodRemission InductionBlood Group IncompatibilityMycophenolic AcidHematopoietic Stem CellsAnemia, Aplastic